title: Pulmonary arterial hypertension: bridging the present to the future.
authors.forename: Marc
authors.initials: M
authors.lastname: Humbert
authors.forename: Rogerio
authors.initials: R
authors.lastname: Souza
authors.forename: Nazzareno
authors.initials: N
authors.lastname: Galiè
authors.forename: Vallerie
authors.initials: V
authors.lastname: McLaughlin
authors.forename: Gérald
authors.initials: G
authors.lastname: Simonneau
authors.forename: Lewis
authors.initials: L
authors.lastname: Rubin
mesh_terms: D017326:Clinical Trials, Phase III as Topic; D003226:Congresses as Topic; D057210:Delayed Diagnosis; D015507:Drugs, Investigational; D042241:Early Diagnosis; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D006330:Heart Defects, Congenital / Q000150:complications; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D010506:Periodicals as Topic; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011743:Pyrimidines / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D018487:Ventricular Dysfunction, Left / Q000150:complications
chemical_list: D015507:Drugs, Investigational; D065130:Endothelin A Receptor Antagonists; D065131:Endothelin B Receptor Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; C533860:macitentan